$NRGN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEUROGEN CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in NEUROGEN CORP. Get notifications about new insider transactions in NEUROGEN CORP for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 24 2009 | NRGN | NEUROGEN CORP | WARBURG PINCUS PRIVATE EQUITY ... | Sell | J | 0.00 | 13,571,411 | 0 | 0 | 13.6 M to 0 (-100.00 %) | |
Dec 24 2009 | NRGN | NEUROGEN CORP | HEN STEWART | Option Exercise | D | 0.00 | 90,042 | 0 | 0 | ||
Dec 24 2009 | NRGN | NEUROGEN CORP | HEN STEWART | Sell | J | 0.00 | 13,571,411 | 0 | 0 | 13.6 M to 0 (-100.00 %) | |
Dec 17 2009 | NRGN | NEUROGEN CORP | BAKER JULIAN | Director | Option Exercise | A | 0.17 | 2,500 | 432 | 2,500 | |
Dec 17 2009 | NRGN | NEUROGEN CORP | BROSHY ERAN | Director | Option Exercise | A | 0.17 | 2,500 | 432 | 2,500 | |
Dec 17 2009 | NRGN | NEUROGEN CORP | HEN STEWART | Director | Option Exercise | A | 0.17 | 2,500 | 432 | 2,500 | |
Dec 17 2009 | NRGN | NEUROGEN CORP | LAMATTINA JOHN L | Director | Option Exercise | A | 0.17 | 2,500 | 432 | 2,500 | |
Dec 17 2009 | NRGN | NEUROGEN CORP | SIMON JOHN | Director | Option Exercise | A | 0.17 | 2,500 | 432 | 2,500 | |
Dec 17 2009 | NRGN | NEUROGEN CORP | SAXTON CRAIG | Director | Option Exercise | A | 0.17 | 2,500 | 432 | 2,500 | |
Sep 16 2009 | NRGN | NEUROGEN CORP | LAMATTINA JOHN L | Director | Option Exercise | A | 0.24 | 2,500 | 590 | 2,500 | |
Sep 16 2009 | NRGN | NEUROGEN CORP | HEN STEWART | Director | Option Exercise | A | 0.24 | 2,500 | 590 | 2,500 | |
Sep 16 2009 | NRGN | NEUROGEN CORP | BAKER JULIAN | Director | Option Exercise | A | 0.24 | 2,500 | 590 | 2,500 | |
Sep 16 2009 | NRGN | NEUROGEN CORP | BROSHY ERAN | Director | Option Exercise | A | 0.24 | 2,500 | 590 | 2,500 | |
Sep 16 2009 | NRGN | NEUROGEN CORP | SAXTON CRAIG | Director | Option Exercise | A | 0.24 | 2,500 | 590 | 2,500 | |
Sep 16 2009 | NRGN | NEUROGEN CORP | SIMON JOHN | Director | Option Exercise | A | 0.24 | 2,500 | 590 | 2,500 | |
Jun 16 2009 | NRGN | NEUROGEN CORP | SAXTON CRAIG | Director | Option Exercise | A | 0.28 | 2,500 | 700 | 2,500 | |
Jun 16 2009 | NRGN | NEUROGEN CORP | SIMON JOHN | Director | Option Exercise | A | 0.28 | 2,500 | 700 | 2,500 | |
Jun 16 2009 | NRGN | NEUROGEN CORP | LAMATTINA JOHN L | Director | Option Exercise | A | 0.28 | 2,500 | 700 | 2,500 | |
Jun 16 2009 | NRGN | NEUROGEN CORP | BROSHY ERAN | Director | Option Exercise | A | 0.28 | 2,500 | 700 | 2,500 | |
Jun 16 2009 | NRGN | NEUROGEN CORP | HEN STEWART | Director | Option Exercise | A | 0.28 | 2,500 | 700 | 2,500 | |
Jun 16 2009 | NRGN | NEUROGEN CORP | BAKER JULIAN | Director | Option Exercise | A | 0.28 | 2,500 | 700 | 2,500 | |
Mar 17 2009 | NRGN | NEUROGEN CORP | HEN STEWART | Director | Option Exercise | A | 0.14 | 2,500 | 350 | 2,500 | |
Mar 17 2009 | NRGN | NEUROGEN CORP | LAMATTINA JOHN L | Director | Option Exercise | A | 0.14 | 2,500 | 350 | 2,500 | |
Mar 17 2009 | NRGN | NEUROGEN CORP | BROSHY ERAN | Director | Option Exercise | A | 0.14 | 2,500 | 350 | 2,500 | |
Mar 17 2009 | NRGN | NEUROGEN CORP | SAXTON CRAIG | Director | Option Exercise | A | 0.14 | 2,500 | 350 | 2,500 | |
Mar 17 2009 | NRGN | NEUROGEN CORP | BAKER JULIAN | Director | Option Exercise | A | 0.14 | 2,500 | 350 | 2,500 | |
Mar 17 2009 | NRGN | NEUROGEN CORP | SIMON JOHN | Director | Option Exercise | A | 0.14 | 2,500 | 350 | 2,500 | |
Dec 17 2008 | NRGN | NEUROGEN CORP | BAKER JULIAN | Director | Option Exercise | A | 0.07 | 2,500 | 186 | 2,500 | |
Dec 17 2008 | NRGN | NEUROGEN CORP | SAXTON CRAIG | Director | Option Exercise | A | 0.07 | 2,500 | 186 | 2,500 | |
Dec 17 2008 | NRGN | NEUROGEN CORP | LAMATTINA JOHN L | Director | Option Exercise | A | 0.07 | 2,500 | 186 | 2,500 | |
Dec 17 2008 | NRGN | NEUROGEN CORP | BROSHY ERAN | Director | Option Exercise | A | 0.07 | 2,500 | 186 | 2,500 | |
Dec 17 2008 | NRGN | NEUROGEN CORP | SIMON JOHN | Director | Option Exercise | A | 0.07 | 2,500 | 186 | 2,500 | |
Nov 13 2008 | NRGN | NEUROGEN CORP | Baker Biotech Capital (GP), LL ... | Director | Option Exercise | C | 0.00 | 50,175 | 0 | 0 | |
Nov 13 2008 | NRGN | NEUROGEN CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | C | 0.00 | 1,304,550 | 0 | 3,500,059 | 2.2 M to 3.5 M (+59.42 %) |
Dec 17 2008 | NRGN | NEUROGEN CORP | HEN STEWART | Director | Option Exercise | A | 0.07 | 2,500 | 186 | 2,500 | |
Nov 13 2008 | NRGN | NEUROGEN CORP | Baker Brothers Life Sciences C ... | Director | Option Exercise | C | 0.00 | 52,737 | 0 | 0 | |
Nov 13 2008 | NRGN | NEUROGEN CORP | Baker Brothers Life Sciences C ... | Director | Buy | C | 0.00 | 1,371,162 | 0 | 3,678,823 | 2.3 M to 3.7 M (+59.42 %) |
Nov 13 2008 | NRGN | NEUROGEN CORP | Baker / Tisch Capital (GP), LL ... | Director | Option Exercise | C | 0.00 | 4,812 | 0 | 0 | |
Nov 13 2008 | NRGN | NEUROGEN CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | C | 0.00 | 125,112 | 0 | 335,668 | 210.6 K to 335.7 K (+59.42 %) |
Nov 13 2008 | NRGN | NEUROGEN CORP | Baker Bros. Capital (GP), LLC | Director | Option Exercise | C | 0.00 | 9,904 | 0 | 0 | |
Nov 13 2008 | NRGN | NEUROGEN CORP | Baker Bros. Capital (GP), LLC | Director | Buy | C | 0.00 | 257,504 | 0 | 690,856 | 433.4 K to 690.9 K (+59.42 %) |
Sep 29 2008 | NRGN | NEUROGEN CORP | HEN STEWART | Director | Option Exercise | A | 0.26 | 1,500 | 390 | 1,500 | |
Sep 29 2008 | NRGN | NEUROGEN CORP | LAMATTINA JOHN L | Director | Option Exercise | A | 0.26 | 1,500 | 390 | 1,500 | |
Sep 29 2008 | NRGN | NEUROGEN CORP | SAXTON CRAIG | Director | Option Exercise | A | 0.26 | 4,500 | 1,170 | 4,500 | |
Sep 29 2008 | NRGN | NEUROGEN CORP | SAXTON CRAIG | Director | Option Exercise | A | 0.26 | 4,500 | 1,170 | 4,500 | |
Sep 29 2008 | NRGN | NEUROGEN CORP | BAKER JULIAN | Director | Option Exercise | A | 0.26 | 4,000 | 1,040 | 4,000 | |
Sep 29 2008 | NRGN | NEUROGEN CORP | BROSHY ERAN | Director | Option Exercise | A | 0.26 | 4,000 | 1,040 | 4,000 | |
Sep 17 2008 | NRGN | NEUROGEN CORP | BROSHY ERAN | Director | Option Exercise | A | 0.31 | 2,500 | 775 | 2,500 | |
Sep 29 2008 | NRGN | NEUROGEN CORP | SIMON JOHN | Director | Option Exercise | A | 0.26 | 4,000 | 1,040 | 4,000 | |
Sep 17 2008 | NRGN | NEUROGEN CORP | LAMATTINA JOHN L | Director | Option Exercise | A | 0.31 | 2,500 | 775 | 2,500 | |
Sep 17 2008 | NRGN | NEUROGEN CORP | HEN STEWART | Director | Option Exercise | A | 0.31 | 2,500 | 775 | 2,500 | |
Sep 17 2008 | NRGN | NEUROGEN CORP | SAXTON CRAIG | Director | Option Exercise | A | 0.31 | 2,500 | 775 | 2,500 | |
Sep 17 2008 | NRGN | NEUROGEN CORP | BAKER JULIAN | Director | Option Exercise | A | 0.31 | 2,500 | 775 | 2,500 | |
Sep 17 2008 | NRGN | NEUROGEN CORP | SIMON JOHN | Director | Option Exercise | A | 0.31 | 2,500 | 775 | 2,500 | |
Jul 29 2008 | NRGN | NEUROGEN CORP | SIMON JOHN | Director | Option Exercise | C | 0.00 | 9,615 | 0 | 0 | |
Jul 29 2008 | NRGN | NEUROGEN CORP | SIMON JOHN | Director | Buy | C | 0.00 | 249,990 | 0 | 308,494 | 58.5 K to 308.5 K (+427.30 %) |
Jul 29 2008 | NRGN | NEUROGEN CORP | Stankovic Srdjan R. | Exec VP and CDO | Option Exercise | A | 1.20 | 96,000 | 115,200 | 96,000 | |
Jul 29 2008 | NRGN | NEUROGEN CORP | DAVIS STEPHEN | President, CEO | Option Exercise | A | 1.20 | 224,000 | 268,800 | 224,000 | |
Jul 29 2008 | NRGN | NEUROGEN CORP | Pitler Thomas A. | SVP, CBO and CFO | Option Exercise | A | 1.20 | 80,000 | 96,000 | 80,000 | |
Jul 28 2008 | NRGN | NEUROGEN CORP | HEN STEWART | Director | Option Exercise | C | 0.00 | 192,307 | 0 | 0 | |
Jul 28 2008 | NRGN | NEUROGEN CORP | HEN STEWART | Director | Buy | C | 0.00 | 4,999,982 | 0 | 13,571,441 | 8.6 M to 13.6 M (+58.33 %) |
Jul 28 2008 | NRGN | NEUROGEN CORP | LEFF JONATHAN S | Director | Option Exercise | C | 0.00 | 192,307 | 0 | 0 | |
Jul 28 2008 | NRGN | NEUROGEN CORP | LEFF JONATHAN S | Director | Buy | C | 0.00 | 4,999,982 | 0 | 13,571,411 | 8.6 M to 13.6 M (+58.33 %) |
Jul 28 2008 | NRGN | NEUROGEN CORP | WARBURG PINCUS PRIVATE EQUITY ... | Director | Option Exercise | C | 0.00 | 192,307 | 0 | 0 | |
Jul 28 2008 | NRGN | NEUROGEN CORP | WARBURG PINCUS PRIVATE EQUITY ... | Director | Buy | C | 0.00 | 4,999,982 | 0 | 13,571,411 | 8.6 M to 13.6 M (+58.33 %) |
Jun 17 2008 | NRGN | NEUROGEN CORP | SIMON JOHN | Director | Option Exercise | A | 0.91 | 2,500 | 2,275 | 2,500 | |
Jun 17 2008 | NRGN | NEUROGEN CORP | BROSHY ERAN | Director | Option Exercise | A | 0.91 | 2,500 | 2,275 | 2,500 | |
Jun 17 2008 | NRGN | NEUROGEN CORP | SAXTON CRAIG | Director | Option Exercise | A | 0.91 | 2,500 | 2,275 | 2,500 | |
Jun 17 2008 | NRGN | NEUROGEN CORP | LEFF JONATHAN S | Director | Option Exercise | A | 0.91 | 2,500 | 2,275 | 2,500 | |
Jun 17 2008 | NRGN | NEUROGEN CORP | LAMATTINA JOHN L | Director | Option Exercise | A | 0.91 | 2,500 | 2,275 | 2,500 | |
Jun 17 2008 | NRGN | NEUROGEN CORP | HEN STEWART | Director | Option Exercise | A | 0.91 | 2,500 | 2,275 | 2,500 | |
Jun 17 2008 | NRGN | NEUROGEN CORP | BAKER JULIAN | Director | Option Exercise | A | 0.91 | 2,500 | 2,275 | 2,500 | |
Jun 17 2008 | NRGN | NEUROGEN CORP | BAKER FELIX | Director | Option Exercise | A | 0.91 | 2,500 | 2,275 | 2,500 | |
Apr 28 2008 | NRGN | NEUROGEN CORP | Pitler Thomas A. | Chief Business Offi ... | Option Exercise | A | 1.20 | 170,000 | 204,000 | 170,000 | |
Apr 28 2008 | NRGN | NEUROGEN CORP | DAVIS STEPHEN | Exec. VP, Chief Ope ... | Option Exercise | A | 1.20 | 476,000 | 571,200 | 476,000 | |
Apr 28 2008 | NRGN | NEUROGEN CORP | Stankovic Srdjan R. | Exec VP and CDO | Option Exercise | A | 1.20 | 204,000 | 244,800 | 204,000 | |
Apr 15 2008 | NRGN | NEUROGEN CORP | SIMON JOHN | Director | Option Exercise | A | 0.00 | 9,615 | 0 | 9,615 | |
Apr 15 2008 | NRGN | NEUROGEN CORP | SIMON JOHN | Director | Option Exercise | A | 0.00 | 9,615 | 0 | 9,615 | |
Apr 15 2008 | NRGN | NEUROGEN CORP | Baker Brothers Life Sciences C ... | Director | Option Exercise | P | 2.30 | 52,737 | 121,295 | 52,737 | |
Apr 15 2008 | NRGN | NEUROGEN CORP | Baker Brothers Life Sciences C ... | Director | Option Exercise | P | 0.00 | 52,737 | 0 | 52,737 | |
Apr 15 2008 | NRGN | NEUROGEN CORP | Baker / Tisch Capital (GP), LL ... | Director | Option Exercise | P | 2.30 | 4,812 | 11,068 | 4,812 | |
Apr 15 2008 | NRGN | NEUROGEN CORP | Baker / Tisch Capital (GP), LL ... | Director | Option Exercise | P | 0.00 | 4,812 | 0 | 4,812 | |
Apr 15 2008 | NRGN | NEUROGEN CORP | Baker Biotech Capital (GP), LL ... | Director | Option Exercise | P | 2.30 | 50,175 | 115,403 | 50,175 | |
Apr 15 2008 | NRGN | NEUROGEN CORP | Baker Biotech Capital (GP), LL ... | Director | Option Exercise | P | 0.00 | 50,175 | 0 | 50,175 | |
Apr 15 2008 | NRGN | NEUROGEN CORP | Baker Bros. Capital (GP), LLC | Director | Option Exercise | P | 2.30 | 9,904 | 22,779 | 9,904 | |
Apr 15 2008 | NRGN | NEUROGEN CORP | Baker Bros. Capital (GP), LLC | Director | Option Exercise | P | 0.00 | 9,904 | 0 | 9,904 | |
Apr 14 2008 | NRGN | NEUROGEN CORP | HEN STEWART | Director | Option Exercise | P | 2.30 | 192,307 | 442,306 | 192,307 | |
Apr 14 2008 | NRGN | NEUROGEN CORP | HEN STEWART | Director | Option Exercise | P | 0.00 | 192,307 | 0 | 192,307 | |
Apr 14 2008 | NRGN | NEUROGEN CORP | LEFF JONATHAN S | Director | Option Exercise | P | 2.30 | 192,307 | 442,306 | 192,307 | |
Apr 14 2008 | NRGN | NEUROGEN CORP | LEFF JONATHAN S | Director | Option Exercise | P | 0.00 | 192,307 | 0 | 192,307 | |
Apr 14 2008 | NRGN | NEUROGEN CORP | WARBURG PINCUS PRIVATE EQUITY ... | 10% Owner | Option Exercise | P | 2.30 | 192,307 | 442,306 | 192,307 | |
Apr 14 2008 | NRGN | NEUROGEN CORP | WARBURG PINCUS PRIVATE EQUITY ... | 10% Owner | Option Exercise | P | 0.00 | 192,307 | 0 | 192,307 | |
Mar 18 2008 | NRGN | NEUROGEN CORP | LAMATTINA JOHN L | Director | Option Exercise | A | 1.59 | 824 | 1,310 | 824 | |
Mar 18 2008 | NRGN | NEUROGEN CORP | SAXTON CRAIG | Director | Option Exercise | A | 1.59 | 2,500 | 3,975 | 2,500 | |
Mar 18 2008 | NRGN | NEUROGEN CORP | SIMON JOHN | Director | Option Exercise | A | 1.59 | 2,500 | 3,975 | 2,500 | |
Mar 18 2008 | NRGN | NEUROGEN CORP | LEFF JONATHAN S | Director | Option Exercise | A | 1.59 | 2,500 | 3,975 | 2,500 | |
Mar 18 2008 | NRGN | NEUROGEN CORP | HEN STEWART | Director | Option Exercise | A | 1.59 | 2,500 | 3,975 | 2,500 | |
Mar 18 2008 | NRGN | NEUROGEN CORP | BROSHY ERAN | Director | Option Exercise | A | 1.59 | 2,500 | 3,975 | 2,500 | |
Mar 18 2008 | NRGN | NEUROGEN CORP | BAKER JULIAN | Director | Option Exercise | A | 1.59 | 2,500 | 3,975 | 2,500 | |
Mar 18 2008 | NRGN | NEUROGEN CORP | BAKER FELIX | Director | Option Exercise | A | 1.59 | 2,500 | 3,975 | 2,500 | |
Dec 21 2007 | NRGN | NEUROGEN CORP | KRAUSE JAMES | Senior VP Biology | Option Exercise | A | 3.56 | 15,750 | 56,070 | 15,750 | |
Dec 21 2007 | NRGN | NEUROGEN CORP | Chenard Bertrand L | SR VP, Chemistry | Option Exercise | A | 3.56 | 15,750 | 56,070 | 15,750 | |
Dec 21 2007 | NRGN | NEUROGEN CORP | HUTCHISON ALAN | Exec VP Discovery R ... | Option Exercise | A | 3.56 | 18,375 | 65,415 | 18,375 | |
Dec 21 2007 | NRGN | NEUROGEN CORP | DAVIS STEPHEN | President | Option Exercise | A | 3.56 | 26,250 | 93,450 | 26,250 | |
Dec 21 2007 | NRGN | NEUROGEN CORP | KOSTER WILLIAM H | Chief Executive Off ... | Option Exercise | A | 3.56 | 31,500 | 112,140 | 31,500 | |
Dec 17 2007 | NRGN | NEUROGEN CORP | SAXTON CRAIG | Director | Option Exercise | A | 2.96 | 2,500 | 7,400 | 2,500 | |
Dec 17 2007 | NRGN | NEUROGEN CORP | SIMON JOHN | Director | Option Exercise | A | 2.96 | 2,500 | 7,400 | 2,500 | |
Dec 17 2007 | NRGN | NEUROGEN CORP | LEFF JONATHAN S | Director | Option Exercise | A | 2.96 | 2,500 | 7,400 | 2,500 | |
Dec 17 2007 | NRGN | NEUROGEN CORP | BROSHY ERAN | Director | Option Exercise | A | 2.96 | 2,500 | 7,400 | 2,500 | |
Dec 17 2007 | NRGN | NEUROGEN CORP | HEN STEWART | Director | Option Exercise | A | 2.96 | 2,500 | 7,400 | 2,500 | |
Dec 17 2007 | NRGN | NEUROGEN CORP | BAKER JULIAN | Director | Option Exercise | A | 2.96 | 2,500 | 7,400 | 2,500 | |
Dec 17 2007 | NRGN | NEUROGEN CORP | BAKER FELIX | Director | Option Exercise | A | 2.96 | 2,500 | 7,400 | 2,500 | |
Sep 17 2007 | NRGN | NEUROGEN CORP | SIMON JOHN | Director | Option Exercise | A | 4.90 | 2,500 | 12,250 | 2,500 | |
Sep 17 2007 | NRGN | NEUROGEN CORP | SAXTON CRAIG | Director | Option Exercise | A | 4.90 | 2,500 | 12,250 | 2,500 | |
Sep 17 2007 | NRGN | NEUROGEN CORP | LEFF JONATHAN S | Director | Option Exercise | A | 4.90 | 2,500 | 12,250 | 2,500 | |
Sep 17 2007 | NRGN | NEUROGEN CORP | HEN STEWART | Director | Option Exercise | A | 4.90 | 2,500 | 12,250 | 2,500 | |
Sep 17 2007 | NRGN | NEUROGEN CORP | BROSHY ERAN | Director | Option Exercise | A | 4.90 | 2,500 | 12,250 | 2,500 | |
Sep 17 2007 | NRGN | NEUROGEN CORP | BAKER JULIAN | Director | Option Exercise | A | 4.90 | 2,500 | 12,250 | 2,500 | |
Sep 17 2007 | NRGN | NEUROGEN CORP | BAKER FELIX | Director | Option Exercise | A | 4.90 | 2,500 | 12,250 | 2,500 | |
Jun 15 2007 | NRGN | NEUROGEN CORP | BROSHY ERAN | Director | Option Exercise | A | 8.47 | 2,500 | 21,175 | 2,500 | |
Jun 15 2007 | NRGN | NEUROGEN CORP | HEN STEWART | Director | Option Exercise | A | 8.47 | 2,500 | 21,175 | 2,500 | |
Jun 15 2007 | NRGN | NEUROGEN CORP | LEFF JONATHAN S | Director | Option Exercise | A | 8.47 | 2,500 | 21,175 | 2,500 | |
Jun 15 2007 | NRGN | NEUROGEN CORP | BAKER FELIX | Director | Option Exercise | A | 8.47 | 2,500 | 21,175 | 2,500 | |
Jun 15 2007 | NRGN | NEUROGEN CORP | SIMON JOHN | Director | Option Exercise | A | 8.47 | 2,500 | 21,175 | 2,500 | |
Jun 15 2007 | NRGN | NEUROGEN CORP | BAKER JULIAN | Director | Option Exercise | A | 8.47 | 2,500 | 21,175 | 2,500 | |
Jun 15 2007 | NRGN | NEUROGEN CORP | SAXTON CRAIG | Director | Option Exercise | A | 8.47 | 2,500 | 21,175 | 2,500 | |
Jun 13 2007 | NRGN | NEUROGEN CORP | Chenard Bertrand L | SR VP, Chemistry | Sell | S | 7.92 | 3,851 | 30,500 | 5,781 | 9.6 K to 5.8 K (-39.98 %) |
Jun 08 2007 | NRGN | NEUROGEN CORP | SIMON JOHN | Director | Option Exercise | A | 7.85 | 4,000 | 31,400 | 4,000 | |
Jun 08 2007 | NRGN | NEUROGEN CORP | SAXTON CRAIG | Director | Option Exercise | A | 7.85 | 5,000 | 39,250 | 5,000 | |
Jun 08 2007 | NRGN | NEUROGEN CORP | LEFF JONATHAN S | Director | Option Exercise | A | 7.85 | 1,500 | 11,775 | 1,500 | |
Jun 08 2007 | NRGN | NEUROGEN CORP | BROSHY ERAN | Director | Option Exercise | A | 7.85 | 4,000 | 31,400 | 4,000 | |
Jun 08 2007 | NRGN | NEUROGEN CORP | HEN STEWART | Director | Option Exercise | A | 7.85 | 3,000 | 23,550 | 3,000 | |
Jun 08 2007 | NRGN | NEUROGEN CORP | BAKER JULIAN | Director | Option Exercise | A | 7.85 | 4,000 | 31,400 | 4,000 | |
Jun 08 2007 | NRGN | NEUROGEN CORP | BAKER FELIX | Director | Option Exercise | A | 7.85 | 1,500 | 11,775 | 1,500 | |
Apr 30 2007 | NRGN | NEUROGEN CORP | HUTCHISON ALAN | EVP, Discovery Rese ... | Sell | S | 6.99 | 200 | 1,398 | 0 | 200 to 0 (-100.00 %) |
Apr 30 2007 | NRGN | NEUROGEN CORP | HUTCHISON ALAN | EVP, Discovery Rese ... | Sell | S | 6.98 | 2,030 | 14,169 | 200 | 2.2 K to 200 (-91.03 %) |
Apr 30 2007 | NRGN | NEUROGEN CORP | HUTCHISON ALAN | EVP, Discovery Rese ... | Sell | S | 6.96 | 470 | 3,271 | 2,230 | 2.7 K to 2.2 K (-17.41 %) |
Apr 30 2007 | NRGN | NEUROGEN CORP | HUTCHISON ALAN | EVP, Discovery Rese ... | Sell | S | 6.95 | 700 | 4,865 | 2,700 | 3.4 K to 2.7 K (-20.59 %) |
Apr 30 2007 | NRGN | NEUROGEN CORP | HUTCHISON ALAN | EVP, Discovery Rese ... | Sell | S | 6.94 | 100 | 694 | 3,400 | 3.5 K to 3.4 K (-2.86 %) |
Apr 30 2007 | NRGN | NEUROGEN CORP | HUTCHISON ALAN | EVP, Discovery Rese ... | Sell | S | 6.93 | 100 | 693 | 3,500 | 3.6 K to 3.5 K (-2.78 %) |
Apr 30 2007 | NRGN | NEUROGEN CORP | HUTCHISON ALAN | EVP, Discovery Rese ... | Sell | S | 6.92 | 400 | 2,768 | 3,600 | 4 K to 3.6 K (-10.00 %) |
Apr 30 2007 | NRGN | NEUROGEN CORP | HUTCHISON ALAN | EVP, Discovery Rese ... | Sell | S | 6.90 | 200 | 1,380 | 4,000 | 4.2 K to 4 K (-4.76 %) |
Apr 30 2007 | NRGN | NEUROGEN CORP | HUTCHISON ALAN | EVP, Discovery Rese ... | Sell | S | 6.89 | 100 | 689 | 4,200 | 4.3 K to 4.2 K (-2.33 %) |
Apr 30 2007 | NRGN | NEUROGEN CORP | HUTCHISON ALAN | EVP, Discovery Rese ... | Sell | S | 6.88 | 200 | 1,376 | 4,300 | 4.5 K to 4.3 K (-4.44 %) |
Apr 30 2007 | NRGN | NEUROGEN CORP | HUTCHISON ALAN | EVP, Discovery Rese ... | Sell | S | 6.87 | 1,100 | 7,557 | 4,500 | 5.6 K to 4.5 K (-19.64 %) |
Apr 30 2007 | NRGN | NEUROGEN CORP | HUTCHISON ALAN | EVP, Discovery Rese ... | Sell | S | 6.86 | 100 | 686 | 5,600 | 5.7 K to 5.6 K (-1.75 %) |
Apr 30 2007 | NRGN | NEUROGEN CORP | HUTCHISON ALAN | EVP, Discovery Rese ... | Sell | S | 6.85 | 400 | 2,740 | 5,700 | 6.1 K to 5.7 K (-6.56 %) |
Apr 30 2007 | NRGN | NEUROGEN CORP | HUTCHISON ALAN | EVP, Discovery Rese ... | Sell | S | 6.84 | 100 | 684 | 6,100 | 6.2 K to 6.1 K (-1.61 %) |
Apr 30 2007 | NRGN | NEUROGEN CORP | HUTCHISON ALAN | EVP, Discovery Rese ... | Sell | S | 6.83 | 400 | 2,732 | 6,200 | 6.6 K to 6.2 K (-6.06 %) |
Apr 30 2007 | NRGN | NEUROGEN CORP | HUTCHISON ALAN | EVP, Discovery Rese ... | Sell | S | 6.82 | 500 | 3,410 | 6,600 | 7.1 K to 6.6 K (-7.04 %) |